Preview

Pediatric pharmacology

Advanced search

The Allergist’s Point of View

https://doi.org/10.15690/pf.v14i4.1769

About the Author

Yuliya G. Levina
National Medical Research Center of Children’s Health
Russian Federation


References

1. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta- agonist treatment of acute asthma. Cochrane Database Syst Rev. 2006;(2):CD000052. doi: 10.1002/14651858.CD000052.pub2.

2. Федеральные клинические рекомендации по оказанию медицинской помощи детям с бронхиальной астмой. — М.: Союз педиатров России; 2016. — 33 с. [Federal’nye klinicheskie rekomendatsii po okazaniyu meditsinskoi pomoshchi detyam s bronkhial’noi astmoi. Moscow: Soyuz pediatrov Rossii; 2016. 33 p. (In Russ).]

3. Fayaz M, Sultan A, Rai ME. Comparison between efficacy of MDI+spacer and nebuliser in the management of acute asthma in children. J Ayub Med Coll Abbottabad. 2009;21(1):32– 34.

4. Breuer O, Shoseyov D, Kerem E, Brooks R. Implementation of a policy change: replacement of nebulizers by spacers for the treatment of asthma in children. Isr Med Assoc J. 2015;17(7):421–424.

5. Laube BL, Janssens HM, de Jongh FH, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37(6):1308–1331. doi: 10.1183/09031936.00166410.

6. Селимзянова Л.Р., Вишнёва Е.А., Промыслова Е.А. Принципы диагностики и терапии бронхиальной астмы у детей на современном этапе: обзор обновлений GINA 2014– 2015 // Педиатрическая фармакология. — 2015. — Т.12. — №3 — С. 290–295. [Selimzyanova LR, Vishneva EA, Promyslova EA. Principles of diagnosis and therapy of bronchial asthma in children at the present stage: GINA 2014–2015 review updates. Pediatric pharmacology. 2015;12(3):290–295. (In Russ).] doi: 10.15690/pf.v12i3.1353.

7. Erzinger S, Schueepp KG, Brooks-Wildhaber J, et al. Face masks and aerosol delivery in vivo. J Aerosol Med. 2007;20 Suppl 1:S78– S84. doi: 10.1089/jam.2007.0572.

8. Brand PL. Inhalation therapy in children with asthma. Minerva Pediatr. 2000;52(3):137–142.

9. Cates CJ, Bestall J, Adams N. Holding chambers versus nebulisers for inhaled steroids in chronic asthma. Cochrane Database Syst Rev. 2006;(1):CD001491. doi: 10.1002/14651858.CD001491.pub2.

10. Boe J, Dennis JH, O’Driscoll BR, et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J. 2001;18(1):228–242. doi: 10.1183/09031936.01.00220001.

11. Rau JL. Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47(11):1257–1275.

12. Butz AM, Eggleston P, Huss K, et al. Children with asthma and nebulizer use: parental asthma self-care practices and beliefs. J Asthma. 2001;38(7):565–573. doi: 10.1081/Jas-100107121.


Review

For citations:


Levina Yu.G. The Allergist’s Point of View. Pediatric pharmacology. 2017;14(4):317-319. (In Russ.) https://doi.org/10.15690/pf.v14i4.1769

Views: 671


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)